{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:43:35Z","timestamp":1791477815779,"version":"4.3.4"},"reference-count":207,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007835","name":"Silesian University of Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007835","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005192","name":"Danmarks Tekniske Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005192","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020816","name":"Kemisk Institut, K\u00f8benhavns Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020816","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bcp.2025.117460","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T14:38:27Z","timestamp":1761403107000},"page":"117460","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"P1","title":["A review on tumor-targeting liposomes: Fabrication, mechanism and applications"],"prefix":"10.1016","volume":"243","author":[{"given":"Suman","family":"Basak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tushar Kanti","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7846-6677","authenticated-orcid":false,"given":"Sayan","family":"Ganguly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2025.117460_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116164","article-title":"H2 antihistamines: May be useful for combination therapies in cancer?","volume":"223","author":"Mohamad","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117460_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00011-025-02054-z","article-title":"Histamine H3 receptor: an emerging target for cancer therapy?","volume":"74","author":"Lauretta","year":"2025","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.bcp.2025.117460_b0015","first-page":"1218","article-title":"The most common side effects experienced by patients were receiving first cycle of chemotherapy","volume":"47","author":"Altun","year":"2018","journal-title":"Iran. J. Public Health"},{"key":"10.1016\/j.bcp.2025.117460_b0020","doi-asserted-by":"crossref","DOI":"10.1021\/acs.biomac.5c01625","article-title":"Enzyme-Immobilized Oxoammonium Nanogels: A Biocompatible and Injectable Platform for Enhanced Enzyme Stability and Reusability","author":"Basak","year":"2025","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.bcp.2025.117460_b0025","article-title":"When complementary and alternative medicine intervenes in the conventional treatment of cancer patients: ethical analysis of a clinical case","volume":"14","author":"Saber","year":"2021","journal-title":"Journal of medical ethics and history of medicine"},{"key":"10.1016\/j.bcp.2025.117460_b0030","article-title":"Gold nanoparticles-mediated photothermal and photodynamic therapies for cancer","volume":"124057","author":"Koc","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bcp.2025.117460_b0035","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12943-023-01865-0","article-title":"Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation","volume":"22","author":"Chehelgerdi","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bcp.2025.117460_b0040","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0748-7983(96)93085-1","article-title":"Systemic toxicity after isolated limb perfusion with melphalan for melanoma","volume":"22","author":"Sonneveld","year":"1996","journal-title":"European Journal of Surgical Oncology (EJSO)"},{"key":"10.1016\/j.bcp.2025.117460_b0045","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2217\/nnm.15.166","article-title":"Nanoparticle systems reduce systemic toxicity in cancer treatment","volume":"11","author":"Wang","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.bcp.2025.117460_b0050","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.3390\/nano12071040","article-title":"Assessment of Systemic Toxicity, Genotoxicity, and Early Phase Hepatocarcinogenicity of Iron (III)-Tannic Acid Nanoparticles in Rats","volume":"12","author":"Hlaing","year":"2022","journal-title":"Nanomaterials"},{"key":"10.1016\/j.bcp.2025.117460_b0055","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s40262-013-0040-2","article-title":"Oral anticancer drugs: mechanisms of low bioavailability and strategies for improvement","volume":"52","author":"Stuurman","year":"2013","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.bcp.2025.117460_b0060","doi-asserted-by":"crossref","first-page":"8038","DOI":"10.3390\/molecules28248038","article-title":"The Bioavailability of Drugs\u2014The Current State of Knowledge","volume":"28","author":"Stielow","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2025.117460_b0065","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41419-024-06697-4","article-title":"Modulating extracellular matrix stiffness: a strategic approach to boost cancer immunotherapy","volume":"15","author":"Mai","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2025.117460_b0070","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.3390\/molecules26185510","article-title":"Lipid-based nanocarrier system for the effective delivery of nutraceuticals","volume":"26","author":"Subramanian","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2025.117460_b0075","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1021\/acsabm.4c01579","article-title":"Zwitterionic, Stimuli-Responsive Liposomes for Curcumin Drug Delivery: Enhancing M2 Macrophage Polarization and Reducing Oxidative Stress through Enzyme-Specific and Hyperthermia-Triggered Release","volume":"8","author":"Basak","year":"2025","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.bcp.2025.117460_b0080","series-title":"and Their Therapeutic Applications, in: Magnetic Polymer Composites and Their Emerging Applications","first-page":"258","article-title":"Surface-Engineered Magnetic Nanoparticles (Iron Oxides)","author":"Ganguly","year":"2024"},{"key":"10.1016\/j.bcp.2025.117460_b0085","doi-asserted-by":"crossref","first-page":"6286","DOI":"10.1021\/acsabm.4c00901","article-title":"Injectable and 3D extrusion printable hydrophilic silicone-based hydrogels for controlled ocular delivery of ophthalmic drugs","volume":"7","author":"Ganguly","year":"2024","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.bcp.2025.117460_b0090","doi-asserted-by":"crossref","first-page":"7201","DOI":"10.1021\/acs.jpcb.8b02919","article-title":"Green reduced graphene oxide toughened semi-IPN monolith hydrogel as dual responsive drug release system: rheological, physicomechanical, and electrical evaluations","volume":"122","author":"Ganguly","year":"2018","journal-title":"The Journal of Physical Chemistry B"},{"key":"10.1016\/j.bcp.2025.117460_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-018-0392-8","article-title":"Nano based drug delivery systems: recent developments and future prospects","volume":"16","author":"Patra","year":"2018","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bcp.2025.117460_b0100","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/6318127","article-title":"Estimation of Abnormal Cell Growth and MCG-Based Discriminative Feature Analysis of Histopathological Breast Images","volume":"2023","author":"Saha","year":"2023","journal-title":"Int. J. Intell. Syst."},{"key":"10.1016\/j.bcp.2025.117460_b0105","series-title":"Injectable Biocompatible RAFT mediated Nitroxide Nanogels: A Robust ROS-Reduction Antioxidant Approach","author":"Basak","year":"2024"},{"key":"10.1016\/j.bcp.2025.117460_b0110","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1039\/D1NA00631B","article-title":"Nanoconfined anti-oxidizing RAFT nitroxide radical polymer for reduction of low-density lipoprotein oxidation and foam cell formation","volume":"4","author":"Basak","year":"2022","journal-title":"Nanoscale Adv."},{"key":"10.1016\/j.bcp.2025.117460_b0115","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1021\/acsanm.1c00397","article-title":"Effect of Nanoparticle Biophysicochemical Properties on Binding and Transport across Cardiovascular Endothelial Dysfunction Models","volume":"4","author":"Bazban-Shotorbani","year":"2021","journal-title":"ACS Appl. Nano Mater."},{"key":"10.1016\/j.bcp.2025.117460_b0120","article-title":"2D nanomaterial for microplastic Removal: A critical review","volume":"152451","author":"Das","year":"2024","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.bcp.2025.117460_b0125","unstructured":"S. Basak, Design, synthesis and development of biologically inspired polymeric nanomedicines for the treatment of advanced atherosclerosis, (2019)."},{"key":"10.1016\/j.bcp.2025.117460_b0130","series-title":"in: 2018 E-MRS Fall Meeting and Exhibit","article-title":"Bioinspired anti-oxidising and anti-atherogenic matrix-metalloproteinase responsive polymeric nanogels","author":"Basak","year":"2018"},{"key":"10.1016\/j.bcp.2025.117460_b0135","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ejpb.2014.03.016","article-title":"RIPL peptide (IPLVVPLRRRRRRRRC)-conjugated liposomes for enhanced intracellular drug delivery to hepsin-expressing cancer cells","volume":"87","author":"Kang","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.bcp.2025.117460_b0140","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejpb.2023.01.007","article-title":"In situ gelling drug delivery systems for topical drug delivery","volume":"184","author":"Kolawole","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.bcp.2025.117460_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2024.158312","article-title":"Cost-effective and eco-friendly sprayable nanogels (ZC-CSNG) for multifunctional wound dressing applications","volume":"503","author":"Basak","year":"2025","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.bcp.2025.117460_b0150","doi-asserted-by":"crossref","first-page":"51940","DOI":"10.1021\/acsami.0c14527","article-title":"Microwave-synthesized polysaccharide-derived carbon dots as therapeutic cargoes and toughening agents for elastomeric gels","volume":"12","author":"Ganguly","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.bcp.2025.117460_b0155","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202314520","article-title":"Borophene based 3D extrusion printed nanocomposite hydrogel for antibacterial and controlled release application","volume":"34","author":"Das","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.bcp.2025.117460_b0160","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3390\/mi16020174","article-title":"Magnetic polymeric conduits in biomedical applications","volume":"16","author":"Ganguly","year":"2025","journal-title":"Micromachines"},{"key":"10.1016\/j.bcp.2025.117460_b0165","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.3390\/pharmaceutics12111054","article-title":"Liposome-based drug delivery systems in cancer immunotherapy","volume":"12","author":"Gu","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bcp.2025.117460_b0170","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0167-7799(98)01220-7","article-title":"Novel applications of liposomes","volume":"16","author":"Lasic","year":"1998","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.bcp.2025.117460_b0175","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.3390\/polym13152529","article-title":"A comprehensive review on the applications of exosomes and liposomes in regenerative medicine and tissue engineering","volume":"13","author":"Shafiei","year":"2021","journal-title":"Polymers"},{"key":"10.1016\/j.bcp.2025.117460_b0180","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1039\/D0NH00605J","article-title":"Targeted liposomal drug delivery: a nanoscience and biophysical perspective","volume":"6","author":"Liu","year":"2021","journal-title":"Nanoscale Horiz."},{"key":"10.1016\/j.bcp.2025.117460_b0185","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.1038\/s41598-020-62500-2","article-title":"Preparation of nanoliposomes by microfluidic mixing in herring-bone channel and the role of membrane fluidity in liposomes formation","volume":"10","author":"Kotou\u010dek","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2025.117460_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e09394","article-title":"Liposomes: Structure, composition, types, and clinical applications","volume":"8","author":"Nsairat","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.bcp.2025.117460_b0195","article-title":"Liposome surface modification by phospholipid chemical reactions","volume":"237","author":"de Lima","year":"2021","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.bcp.2025.117460_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116277","article-title":"Risk factors of using late-autophagy inhibitors: Aspects to consider when combined with anticancer therapies","volume":"225","author":"Skrzeszewski","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117460_b0205","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202100639","article-title":"Liposomes and extracellular vesicles as drug delivery systems: A comparison of composition, pharmacokinetics, and functionalization","volume":"11","author":"van der Koog","year":"2022","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.bcp.2025.117460_b0210","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3390\/pharmaceutics12030264","article-title":"Liposomes for enhanced bioavailability of water-insoluble drugs: In vivo evidence and recent approaches","volume":"12","author":"Lee","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bcp.2025.117460_b0215","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3390\/nano10020190","article-title":"Immunological and toxicological considerations for the design of liposomes","volume":"10","author":"Inglut","year":"2020","journal-title":"Nanomaterials"},{"key":"10.1016\/j.bcp.2025.117460_b0220","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1368-7646(03)00082-7","article-title":"Liposome-based approaches to overcome anticancer drug resistance","volume":"6","author":"Mamot","year":"2003","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.bcp.2025.117460_b0225","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/10717540601098799","article-title":"Liposome formulation of paclitaxel with enhanced solubility and stability","volume":"14","author":"Yang","year":"2007","journal-title":"Drug Deliv."},{"key":"10.1016\/j.bcp.2025.117460_b0230","doi-asserted-by":"crossref","first-page":"782","DOI":"10.3390\/polym15030782","article-title":"Coating materials to increase the stability of liposomes","volume":"15","author":"Pasarin","year":"2023","journal-title":"Polymers"},{"key":"10.1016\/j.bcp.2025.117460_b0235","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202400969","article-title":"Advancements in Targeted Therapies for Colorectal Cancer: Innovative Drug Formulation and Delivery Strategies","volume":"358","author":"Firouzjaei","year":"2025","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bcp.2025.117460_b0240","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fphar.2015.00286","article-title":"Advances and challenges of liposome assisted drug delivery","volume":"6","author":"Sercombe","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117460_b0245","doi-asserted-by":"crossref","DOI":"10.36922\/arnm.4373","article-title":"Applications of radionuclide-carrying liposomes for diagnosis and treatment of cancer","volume":"2","author":"Basu","year":"2024","journal-title":"ARNM"},{"key":"10.1016\/j.bcp.2025.117460_b0250","article-title":"NGR-Modified CAF-Derived exos Targeting Tumor Vasculature to Induce Ferroptosis and Overcome Chemoresistance in Osteosarcoma","volume":"12","author":"Du","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bcp.2025.117460_b0255","first-page":"1582","article-title":"Precisely Tailoring Molecular Structure of Doxorubicin Prodrugs to Enable Stable Nanoassembly","volume":"16","author":"Feng","year":"2024","journal-title":"Rapid Activation, and Potent Antitumor Effect, Pharmaceutics"},{"key":"10.1016\/j.bcp.2025.117460_b0260","doi-asserted-by":"crossref","first-page":"636","DOI":"10.3390\/molecules29030636","article-title":"Light-Responsive and Dual-Targeting Liposomes: From Mechanisms to Targeting Strategies","volume":"29","author":"Agiba","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2025.117460_b0265","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/onco5010002","article-title":"Dual approaches in oncology: The promise of siRNA and chemotherapy combinations in cancer therapies","volume":"5","author":"Sousa","year":"2025","journal-title":"Onco"},{"key":"10.1016\/j.bcp.2025.117460_b0270","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1080\/08982104.2024.2315449","article-title":"Remote loading in liposome: a review of current strategies and recent developments","volume":"34","author":"Nambiar","year":"2024","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.bcp.2025.117460_b0275","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3923\/ijp.2023.367.380","article-title":"Remotely Rutin-Loaded into Liposomes for Efficient Encapsulation and Enhancement of Bioavailability and Brain Targeting in vivo","volume":"19","author":"Pan","year":"2023","journal-title":"IJP"},{"key":"10.1016\/j.bcp.2025.117460_b0280","article-title":"Stearoyl-CoA desaturase 1: An important factor in lipid metabolism in colorectal cancer","volume":"117239","author":"Xue","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117460_b0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.116778","article-title":"Preclinical evaluation of new drug-drug interactions of lomitapide: A proposal for novel mechanism of interaction associated with lipid metabolic changes","volume":"233","author":"Ito","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117460_b0290","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1038\/s41467-018-05118-3","article-title":"Controlled gene and drug release from a liposomal delivery platform triggered by X-ray radiation","volume":"9","author":"Deng","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2025.117460_b0295","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0959-8049(01)00050-8","article-title":"Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL\u00ae\/CAELYX\u00ae) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group","volume":"37","author":"Judson","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bcp.2025.117460_b0300","doi-asserted-by":"crossref","first-page":"e1179","DOI":"10.1016\/S2214-109X(22)00242-X","article-title":"Evaluation of four chemotherapy regimens for treatment of advanced AIDS-associated Kaposi sarcoma in Kenya: a cost-effectiveness analysis","volume":"10","author":"Freeman","year":"2022","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.bcp.2025.117460_b0305","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s002800051025","article-title":"The pharmacokinetics of liposomal encapsulated daunorubicin are not modified by HAART in patients with HIV-associated Kaposi's sarcoma","volume":"45","author":"Fumagalli","year":"2000","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117460_b0310","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s40265-017-0741-1","article-title":"Liposomal irinotecan: a review in metastatic pancreatic adenocarcinoma","volume":"77","author":"Lamb","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.bcp.2025.117460_b0315","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s40259-012-0002-5","article-title":"Vincristine sulfate liposome injection: a guide to its use in refractory or relapsed acute lymphoblastic leukemia","volume":"27","author":"Harrison","year":"2013","journal-title":"BioDrugs"},{"key":"10.1016\/j.bcp.2025.117460_b0320","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.clml.2013.10.012","article-title":"High-dose vincristine sulfate liposome injection (Marqibo) is not associated with clinically meaningful hematologic toxicity","volume":"14","author":"Deitcher","year":"2014","journal-title":"Clinical Lymphoma Myeloma and Leukemia"},{"key":"10.1016\/j.bcp.2025.117460_b0325","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3390\/ph18030402","article-title":"Combating antibiotic resistance: Mechanisms, multidrug-resistant pathogens, and novel therapeutic approaches: An updated review","volume":"18","author":"Elshobary","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bcp.2025.117460_b0330","first-page":"1","article-title":"Understanding and overcoming multidrug resistance in cancer","author":"Ge","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bcp.2025.117460_b0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107099","article-title":"Natural products for combating multidrug resistance in cancer","volume":"202","author":"Chen","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2025.117460_b0340","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.2147\/IJN.S453566","article-title":"Recent advances in understanding the molecular mechanisms of multidrug resistance and novel approaches of CRISPR\/Cas9-based genome-editing to combat this health emergency","author":"Allemailem","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.bcp.2025.117460_b0345","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11046-024-00832-7","article-title":"Genome-wide analysis of in vivo-evolved Candida auris reveals multidrug-resistance mechanisms","volume":"189","author":"Chen","year":"2024","journal-title":"Mycopathologia"},{"key":"10.1016\/j.bcp.2025.117460_b0350","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13045-024-01574-1","article-title":"Lipid-based nanosystems: the next generation of cancer immune therapy","volume":"17","author":"Cheng","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bcp.2025.117460_b0355","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jconrel.2017.01.004","article-title":"Encapsulation of two different TLR ligands into liposomes confer protective immunity and prevent tumor development","volume":"247","author":"Bayyurt","year":"2017","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.bcp.2025.117460_b0360","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jconrel.2024.07.015","article-title":"Therapeutic liposomal combination to enhance chemotherapy response and immune activation of tumor microenvironment","volume":"373","author":"Gu","year":"2024","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.bcp.2025.117460_b0365","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3390\/jpm11060571","article-title":"Recent advances in tumor targeting via EPR effect for cancer treatment","volume":"11","author":"Subhan","year":"2021","journal-title":"Journal of personalized medicine"},{"key":"10.1016\/j.bcp.2025.117460_b0370","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1016\/j.drudis.2022.04.011","article-title":"Recent advances in dual-ligand targeted nanocarriers for cancer therapy","volume":"27","author":"Khan","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bcp.2025.117460_b0375","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2014.21","article-title":"Cell-type-specific, aptamer-functionalized agents for targeted disease therapy","volume":"3","author":"Zhou","year":"2014","journal-title":"Molecular therapy Nucleic acids"},{"key":"10.1016\/j.bcp.2025.117460_b0380","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00109-018-1669-y","article-title":"Bispecific therapeutic aptamers for targeted therapy of cancer: a review on cellular perspective","volume":"96","author":"Vandghanooni","year":"2018","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.bcp.2025.117460_b0385","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd4519","article-title":"Principles in the design of ligand-targeted cancer therapeutics and imaging agents","volume":"14","author":"Srinivasarao","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2025.117460_b0390","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1021\/acs.biomac.8b01510","article-title":"Tumor microenvironmental pH and enzyme dual responsive polymer-liposomes for synergistic treatment of cancer immuno-chemotherapy","volume":"20","author":"Liu","year":"2019","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.bcp.2025.117460_b0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122442","article-title":"Boosting the synergism between cancer ferroptosis and immunotherapy via targeted stimuli-responsive liposomes","volume":"305","author":"Gao","year":"2024","journal-title":"Biomaterials"},{"key":"10.1016\/j.bcp.2025.117460_b0400","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.2147\/IJN.S470637","article-title":"Stimulus-responsive nanodelivery and release systems for cancer gene therapy: efficacy improvement strategies","author":"Zeng","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.bcp.2025.117460_b0405","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1021\/acsabm.4c01579","article-title":"Zwitterionic, stimuli-responsive liposomes for curcumin drug delivery: enhancing M2 macrophage polarization and reducing oxidative stress through enzyme-specific and hyperthermia-triggered release","volume":"8","author":"Basak","year":"2024","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.bcp.2025.117460_b0410","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202302902","article-title":"Insights into targeted and stimulus\u2010responsive nanocarriers for brain cancer treatment","volume":"13","author":"Abousalman-Rezvani","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.bcp.2025.117460_b0415","doi-asserted-by":"crossref","first-page":"5272","DOI":"10.1021\/acsanm.3c05543","article-title":"Superparamagnetic amine-functionalized maghemite nanoparticles as a thixotropy promoter for hydrogels and magnetic field-driven diffusion-controlled drug release","volume":"7","author":"Ganguly","year":"2024","journal-title":"ACS Appl. Nano Mater."},{"key":"10.1016\/j.bcp.2025.117460_b0420","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.3390\/polym13234259","article-title":"Design of magnetic hydrogels for hyperthermia and drug delivery","volume":"13","author":"Ganguly","year":"2021","journal-title":"Polymers"},{"key":"10.1016\/j.bcp.2025.117460_b0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.progpolymsci.2022.101574","article-title":"3D printed magnetic polymer composite hydrogels for hyperthermia and magnetic field driven structural manipulation","volume":"131","author":"Ganguly","year":"2022","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.bcp.2025.117460_b0430","doi-asserted-by":"crossref","first-page":"6380","DOI":"10.3390\/ijms21176380","article-title":"Stimulus-responsive nanomedicines for disease diagnosis and treatment","volume":"21","author":"Liu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.117460_b0435","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40164-025-00602-1","article-title":"Applications of liposomes and lipid nanoparticles in cancer therapy: current advances and prospects","volume":"14","author":"Cheng","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.bcp.2025.117460_b0440","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.3390\/ijms24032643","article-title":"Liposomes for tumor targeted therapy: a review","volume":"24","author":"Wang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.117460_b0445","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-024-02024-9","article-title":"New-generation advanced PROTACs as potential therapeutic agents in cancer therapy","volume":"23","author":"Wang","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bcp.2025.117460_b0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2020.100024","article-title":"Combination therapy based on nano codelivery for overcoming cancer drug resistance","volume":"6","author":"Wang","year":"2020","journal-title":"Med. Drug Discovery"},{"key":"10.1016\/j.bcp.2025.117460_b0455","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12951-022-01251-w","article-title":"Nanocarriers surface engineered with cell membranes for cancer targeted chemotherapy","volume":"20","author":"Lei","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bcp.2025.117460_b0460","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/pj.2012.215","article-title":"Peptide-based targeting strategies for simultaneous imaging and therapy with nanovectors","volume":"45","author":"Accardo","year":"2013","journal-title":"Polym. J."},{"key":"10.1016\/j.bcp.2025.117460_b0465","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3390\/ph14030221","article-title":"Lipidated peptidomimetic ligand-functionalized HER2 targeted liposome as nano-carrier designed for doxorubicin delivery in cancer therapy","volume":"14","author":"Naik","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bcp.2025.117460_b0470","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/s42003-020-1016-z","article-title":"Liposomal nanotheranostics for multimode targeted in vivo bioimaging and near\u2010infrared light mediated cancer therapy","volume":"3","author":"Prasad","year":"2020","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bcp.2025.117460_b0475","doi-asserted-by":"crossref","first-page":"125","DOI":"10.7150\/ntno.52168","article-title":"MR-labelled liposomes and focused ultrasound for spatiotemporally controlled drug release in triple negative breast cancers in mice","volume":"5","author":"Amrahli","year":"2021","journal-title":"Nanotheranostics"},{"key":"10.1016\/j.bcp.2025.117460_b0480","series-title":"Current status and prospects for improved targeted delivery approaches for cancer","author":"Mansouri","year":"2023"},{"key":"10.1016\/j.bcp.2025.117460_b0485","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3390\/pharmaceutics11080381","article-title":"Formulation strategies for folate-targeted liposomes and their biomedical applications","volume":"11","author":"Kumar","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bcp.2025.117460_b0490","doi-asserted-by":"crossref","first-page":"20548","DOI":"10.1038\/s41598-023-47988-8","article-title":"Predicting intratumoral fluid pressure and liposome accumulation using physics informed deep learning","volume":"13","author":"Meaney","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2025.117460_b0495","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1021\/acs.bioconjchem.4c00254","article-title":"A New Age of Drug Delivery: A Comparative Perspective of Ferritin\u2013Drug Conjugates","volume":"35","author":"Hong","year":"2024","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.bcp.2025.117460_b0500","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1021\/acs.bioconjchem.4c00576","article-title":"Ferritin versus Liposomes: A Comparative Analysis of Protein- and Lipid-Based Drug Delivery Systems","volume":"36","author":"Liu","year":"2025","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.bcp.2025.117460_b0505","first-page":"1793","article-title":"MR analysis of the corpus callosum, AJNR","volume":"18","author":"Gabrielli","year":"1997","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.bcp.2025.117460_b0510","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa2301972","article-title":"Triple\u2013hormone-receptor agonist retatrutide for obesity\u2014a phase 2 trial","volume":"389","author":"Jastreboff","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2025.117460_b0515","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1056\/NEJMoa1209124","article-title":"Trastuzumab emtansine for HER2-positive advanced breast cancer","volume":"367","author":"Verma","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2025.117460_b0520","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nrclinonc.2016.35","article-title":"Translating neoadjuvant therapy into survival benefits: one size does not fit all","volume":"13","author":"De Mattos-Arruda","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bcp.2025.117460_b0525","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2025.117460_b0530","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1056\/NEJMoa1503093","article-title":"Pembrolizumab versus ipilimumab in advanced melanoma","volume":"372","author":"Robert","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2025.117460_b0535","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1056\/NEJMoa040938","article-title":"Activating mutations in the epidermal growth factor receptor underlying responsiveness of non\u2013small-cell lung cancer to gefitinib","volume":"350","author":"Lynch","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2025.117460_b0540","first-page":"1","article-title":"Talimogene laherparepvec (T-VEC) for the treatment of advanced locoregional melanoma after failure of immunotherapy: an international multi-institutional experience","author":"Carr","year":"2022","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.bcp.2025.117460_b0545","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201805888","article-title":"Tumor microenvironment\u2010activatable prodrug vesicles for nanoenabled cancer chemoimmunotherapy combining immunogenic cell death induction and CD47 blockade","volume":"31","author":"Zhou","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bcp.2025.117460_b0550","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/s41401-019-0281-1","article-title":"Overview of recent advances in liposomal nanoparticle-based cancer immunotherapy","volume":"40","author":"Gao","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bcp.2025.117460_b0555","doi-asserted-by":"crossref","first-page":"3","DOI":"10.15171\/apb.2017.002","article-title":"Application of various types of liposomes in drug delivery systems","volume":"7","author":"Alavi","year":"2017","journal-title":"Advanced pharmaceutical bulletin"},{"key":"10.1016\/j.bcp.2025.117460_b0560","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejpb.2019.04.013","article-title":"The suitability of liposomes for the delivery of hydrophobic drugs\u2013a case study with curcumin","volume":"140","author":"Kolter","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.bcp.2025.117460_b0565","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.apsb.2018.06.005","article-title":"Adapting liposomes for oral drug delivery","volume":"9","author":"He","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bcp.2025.117460_b0570","doi-asserted-by":"crossref","first-page":"12844","DOI":"10.3390\/ijms241612844","article-title":"Liposome-Based Carriers for CRISPR Genome Editing","volume":"24","author":"Yin","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.117460_b0575","doi-asserted-by":"crossref","DOI":"10.1177\/1534735419876345","article-title":"The role of hyperthermia in the multidisciplinary treatment of malignant tumors","volume":"18","author":"Cheng","year":"2019","journal-title":"Integr. Cancer Ther."},{"key":"10.1016\/j.bcp.2025.117460_b0580","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jconrel.2022.08.001","article-title":"Stimuli-responsive liposomal nanoformulations in cancer therapy: Pre-clinical & clinical approaches","volume":"351","author":"Ashrafizadeh","year":"2022","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.bcp.2025.117460_b0585","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1021\/acs.bioconjchem.6b00736","article-title":"Enzyme-responsive liposomes for the delivery of anticancer drugs","volume":"28","author":"Fouladi","year":"2017","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.bcp.2025.117460_b0590","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0005-2736(98)00041-8","article-title":"Triggerable liposomal fusion by enzyme cleavage of a novel peptide\u2013lipid conjugate","volume":"1372","author":"Pak","year":"1998","journal-title":"Biochimica et Biophysica Acta (BBA)-Biomembranes"},{"key":"10.1016\/j.bcp.2025.117460_b0595","doi-asserted-by":"crossref","first-page":"18658","DOI":"10.1021\/acsami.6b05678","article-title":"Switchable liposomes: targeting-peptide-functionalized and pH-triggered cytoplasmic delivery","volume":"8","author":"Han","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.bcp.2025.117460_b0600","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1211\/jpp.59.4.0001","article-title":"pH\u2010Sensitive liposomes\u2010principle and application in cancer therapy","volume":"59","author":"Karanth","year":"2007","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117460_b0605","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3109\/08982109309148213","article-title":"pH-sensitive liposomes","volume":"3","author":"Torchilin","year":"1993","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.bcp.2025.117460_b0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114821","article-title":"Recent progress in NIR-II fluorescence imaging-guided drug delivery for cancer theranostics","volume":"197","author":"Roy","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bcp.2025.117460_b0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114536","article-title":"Multifunctional nanotheranostics for near infrared optical imaging-guided treatment of brain tumors","volume":"190","author":"Zhang","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bcp.2025.117460_b0620","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.addr.2009.11.021","article-title":"Surface modifications of nanocarriers for effective intracellular delivery of anti-HIV drugs","volume":"62","author":"Gunaseelan","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bcp.2025.117460_b0625","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jconrel.2009.01.018","article-title":"Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles","volume":"135","author":"Nam","year":"2009","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.bcp.2025.117460_b0630","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1016\/j.biomaterials.2011.01.075","article-title":"The fine-tuning of thermosensitive and degradable polymer micelles for enhancing intracellular uptake and drug release in tumors","volume":"32","author":"Li","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.bcp.2025.117460_b0635","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3390\/pharmaceutics14040778","article-title":"Polymer-modified liposomes for drug delivery: from fundamentals to applications","volume":"14","author":"Cao","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bcp.2025.117460_b0640","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.3390\/life13112158","article-title":"Preparing Size-Controlled Liposomes Modified with Polysaccharide Derivatives for pH-Responsive Drug Delivery Applications","volume":"13","author":"Yanagihara","year":"2023","journal-title":"Life"},{"key":"10.1016\/j.bcp.2025.117460_b0645","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jcis.2023.11.059","article-title":"Cell interactions with lipid nanoparticles possessing different internal nanostructures: Liposomes, bicontinuous cubosomes, hexosomes, and discontinuous micellar cubosomes","volume":"656","author":"Yap","year":"2024","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.bcp.2025.117460_b0650","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1388-9842(01)00201-X","article-title":"Chemotherapy\u2010induced cardiotoxicity: current practice and prospects of prophylaxis","volume":"4","author":"Gharib","year":"2002","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.bcp.2025.117460_b0655","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1021\/ar7000815","article-title":"Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases","volume":"41","author":"Low","year":"2008","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.bcp.2025.117460_b0660","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/wnan.37","article-title":"Methotrexate delivery via folate targeted dendrimer\u2010based nanotherapeutic platform","volume":"1","author":"Majoros","year":"2009","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.bcp.2025.117460_b0665","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.addr.2009.11.007","article-title":"Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer","volume":"62","author":"Patra","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bcp.2025.117460_b0670","doi-asserted-by":"crossref","first-page":"6317","DOI":"10.1016\/j.biomaterials.2010.04.043","article-title":"Polyethyleneimine-modified iron oxide nanoparticles for brain tumor drug delivery using magnetic targeting and intra-carotid administration","volume":"31","author":"Chertok","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.bcp.2025.117460_b0675","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202301133","article-title":"Enhanced liposomal drug delivery via membrane fusion triggered by dimeric coiled\u2010coil peptides","volume":"19","author":"Zeng","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.bcp.2025.117460_b0680","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jconrel.2023.09.022","article-title":"Control of cell penetration enhancer shielding and endosomal escape-kinetics crucial for efficient and biocompatible siRNA delivery","volume":"363","author":"Malfanti","year":"2023","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.bcp.2025.117460_b0685","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.omtn.2017.04.015","article-title":"Light-triggerable liposomes for enhanced endolysosomal escape and gene silencing in PC12 cells","volume":"7","author":"Chen","year":"2017","journal-title":"Molecular Therapy-Nucleic Acids"},{"key":"10.1016\/j.bcp.2025.117460_b0690","doi-asserted-by":"crossref","DOI":"10.1039\/D4NA00086B","article-title":"Cutting-edge approaches for targeted drug delivery in breast cancer: beyond conventional therapies","author":"Chaudhari","year":"2024","journal-title":"Nanoscale Adv."},{"key":"10.1016\/j.bcp.2025.117460_b0695","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41392-023-01536-y","article-title":"Nanomedicine in cancer therapy","volume":"8","author":"Fan","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bcp.2025.117460_b0700","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1080\/10717544.2022.2089296","article-title":"Functional ligands for improving anticancer drug therapy: current status and applications to drug delivery systems","volume":"29","author":"Bajracharya","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.bcp.2025.117460_b0705","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3390\/pharmaceutics16020248","article-title":"Different Targeting Ligands-Mediated Drug Delivery Systems for Tumor Therapy","volume":"16","author":"Yan","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bcp.2025.117460_b0710","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrd1632","article-title":"Recent advances with liposomes as pharmaceutical carriers","volume":"4","author":"Torchilin","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2025.117460_b0715","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: from concept to clinical applications","volume":"65","author":"Allen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bcp.2025.117460_b0720","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1080\/10717544.2016.1177136","article-title":"Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape","volume":"23","author":"Zylberberg","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.bcp.2025.117460_b0725","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2147\/IJN.S68861","article-title":"Liposomes as nanomedical devices","author":"Bozzuto","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.bcp.2025.117460_b0730","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/j.addr.2012.06.013","article-title":"Immunotoxicity derived from manipulating leukocytes with lipid-based nanoparticles","volume":"64","author":"Peer","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bcp.2025.117460_b0735","doi-asserted-by":"crossref","first-page":"6867","DOI":"10.1016\/j.biomaterials.2010.05.027","article-title":"The systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activation","volume":"31","author":"Kedmi","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.bcp.2025.117460_b0740","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/0192623307310960","article-title":"Liposomal nanomedicines: an emerging field","volume":"36","author":"Fenske","year":"2008","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.bcp.2025.117460_b0745","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1517\/17425247.2015.1086745","article-title":"Intracellular delivery of nanocarriers and targeting to subcellular organelles","volume":"13","author":"Jhaveri","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.bcp.2025.117460_b0750","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.drup.2016.10.003","article-title":"New insights and evolving role of pegylated liposomal doxorubicin in cancer therapy","volume":"29","author":"Gabizon","year":"2016","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.bcp.2025.117460_b0755","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3390\/ijms22020820","article-title":"A step-by-step approach to improve clinical translation of liposome-based nanomaterials, a focus on innate immune and inflammatory responses","volume":"22","author":"Della Camera","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.117460_b0760","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ijpharm.2014.08.066","article-title":"Development of liposomal and microemulsion formulations for transdermal delivery of clonazepam: Effect of randomly methylated \u03b2-cyclodextrin","volume":"475","author":"Mura","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bcp.2025.117460_b0765","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.colsurfa.2017.04.037","article-title":"Effect of preparation protocol on physicochemical features and biointeractions of pegylated liposomes","volume":"532","author":"Giansanti","year":"2017","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"key":"10.1016\/j.bcp.2025.117460_b0770","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ijpharm.2018.04.030","article-title":"Preparation of drug-loaded small unilamellar liposomes and evaluation of their potential for the treatment of chronic respiratory diseases","volume":"545","author":"De Leo","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bcp.2025.117460_b0775","doi-asserted-by":"crossref","DOI":"10.1016\/j.lwt.2021.113044","article-title":"Encapsulation of bioactive fermented wheat (Lisosan G) in Eudragit-liposomes","volume":"156","author":"Gabriele","year":"2022","journal-title":"LWT"},{"key":"10.1016\/j.bcp.2025.117460_b0780","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fphar.2018.00080","article-title":"Advantages and limitations of current imaging techniques for characterizing liposome morphology","volume":"9","author":"Robson","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117460_b0785","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jconrel.2011.11.029","article-title":"Quantitative structure-property relationship modeling of remote liposome loading of drugs","volume":"160","author":"Cern","year":"2012","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.bcp.2025.117460_b0790","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jconrel.2006.01.005","article-title":"Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes","volume":"112","author":"Ishida","year":"2006","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.bcp.2025.117460_b0795","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1016\/j.csbj.2020.07.015","article-title":"Novel zwitterionic vectors: Multi-functional delivery systems for therapeutic genes and drugs","volume":"18","author":"Zhou","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.bcp.2025.117460_b0800","article-title":"Lipid Nanoparticles With Fine\u2010Tuned Composition Show Enhanced Colon Targeting as a Platform for mRNA Therapeutics","volume":"2408744","author":"Rampado","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bcp.2025.117460_b0805","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1053\/j.seminoncol.2004.08.002","article-title":"Pegylated liposomal doxorubicin: Proof of principle using preclinical animal models and pharmacokinetic studies","volume":"31","author":"Vail","year":"2004","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.bcp.2025.117460_b0810","doi-asserted-by":"crossref","first-page":"e4171","DOI":"10.1371\/journal.pone.0004171","article-title":"A novel peptide enhances therapeutic efficacy of liposomal anti-cancer drugs in mice models of human lung cancer","volume":"4","author":"Chang","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2025.117460_b0815","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114021","article-title":"Preclinical validation of a new hybrid molecule loaded in liposomes for melanoma management","volume":"157","author":"Pinho","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2025.117460_b0820","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13346-023-01389-6","article-title":"Vincristine-based nanoformulations: A preclinical and clinical studies overview","volume":"14","author":"Shukla","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.bcp.2025.117460_b0825","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2024.114085","article-title":"Liposomal delivery of organoselenium-cisplatin complex as a novel therapeutic approach for colon cancer therapy","volume":"242","author":"Khabbazian","year":"2024","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.bcp.2025.117460_b0830","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.3390\/pharmaceutics15071824","article-title":"A Systematic Review of Clinical Trials on the Efficacy and Safety of CRLX101 Cyclodextrin-Based Nanomedicine for Cancer Treatment","volume":"15","author":"Serrano-Mart\u00ednez","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bcp.2025.117460_b0835","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1200\/PO.20.00214","article-title":"Revisiting risk and benefit in early oncology trials in the era of precision medicine: a systematic review and meta-analysis of phase I trials of targeted single-agent anticancer therapies","volume":"5","author":"Mackley","year":"2021","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.bcp.2025.117460_b0840","doi-asserted-by":"crossref","unstructured":"F.R. Brennan, L.D. Morton, S. Spindeldreher, A. Kiessling, R. Allenspach, A. Hey, P. M\u00fcller, W. Frings, J. Sims, Safety and immunotoxicity assessment of immunomodulatory monoclonal antibodies, in: MAbs, vol. 2, Taylor & Francis, 2010, pp. 233-255.","DOI":"10.4161\/mabs.2.3.11782"},{"key":"10.1016\/j.bcp.2025.117460_b0845","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s41573-022-00633-x","article-title":"The evolving role of investigative toxicology in the pharmaceutical industry","volume":"22","author":"Pognan","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2025.117460_b0850","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1039\/D3MA00629H","article-title":"Circumventing challenges in mitochondrial targeting for cancer treatment: leveraging nanoplatforms for effective solutions","volume":"5","author":"Pandya","year":"2024","journal-title":"Mater. Adv."},{"key":"10.1016\/j.bcp.2025.117460_b0855","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1021\/acsomega.2c04078","article-title":"Advances in lung cancer treatment using nanomedicines","volume":"8","author":"Sharma","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.bcp.2025.117460_b0860","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3390\/life14060672","article-title":"Targeted liposomal drug delivery: Overview of the current applications and challenges","volume":"14","author":"Gatto","year":"2024","journal-title":"Life"},{"key":"10.1016\/j.bcp.2025.117460_b0865","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1080\/17425247.2024.2394611","article-title":"Liposomal drug delivery systems for organ-specific cancer targeting: early promises, subsequent problems, and recent breakthroughs","volume":"21","author":"Zahednezhad","year":"2024","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.bcp.2025.117460_b0870","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/chemengineering9030056","article-title":"Liposome-based drug delivery systems: from laboratory research to industrial production\u2014instruments and challenges","volume":"9","author":"Basak","year":"2025","journal-title":"ChemEngineering"},{"key":"10.1016\/j.bcp.2025.117460_b0875","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.133065","article-title":"Alginate nanogel-embedded liposomal drug carriers facilitate drug delivery efficiency in arthritis treatment","volume":"273","author":"Lin","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bcp.2025.117460_b0880","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.3390\/pharmaceutics15112623","article-title":"Translational Challenges and Prospective Solutions in the Implementation of Biomimetic Delivery Systems","volume":"15","author":"Wang","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bcp.2025.117460_b0885","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1021\/acsmaterialsau.3c00032","article-title":"Lipid-based nanoparticles for drug\/gene delivery: an overview of the production techniques and difficulties encountered in their industrial development","volume":"3","author":"Mehta","year":"2023","journal-title":"ACS Mater. Au"},{"key":"10.1016\/j.bcp.2025.117460_b0890","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2022.12.013","article-title":"Liposome-based diagnostic and therapeutic applications for pancreatic cancer","volume":"157","author":"Raza","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bcp.2025.117460_b0895","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.2147\/IJN.S298159","article-title":"Recent advances in macrophage-mediated drug delivery systems","author":"Liang","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.bcp.2025.117460_b0900","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e09575","article-title":"Liposomes: An emerging carrier for targeting Alzheimer's and Parkinson's diseases","volume":"8","author":"Pandian","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.bcp.2025.117460_b0905","first-page":"297","article-title":"Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential","volume":"1","author":"Laura Immordino","year":"2006","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.bcp.2025.117460_b0910","article-title":"Interplay between Liposomes and IgM: Principles","volume":"10","author":"Wang","year":"2023","journal-title":"Challenges, and Opportunities, Advanced Science"},{"key":"10.1016\/j.bcp.2025.117460_b0915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-021-01096-0","article-title":"Nanomaterials for cancer therapy: current progress and perspectives","volume":"14","author":"Cheng","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bcp.2025.117460_b0920","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1125093","article-title":"Lipid-engineered nanotherapeutics for cancer management","volume":"14","author":"Fernandez-Fernandez","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117460_b0925","article-title":"Novel redox\u2010responsive polymeric magnetosomes with tunable magnetic resonance property for in vivo drug release visualization and dual\u2010modal cancer therapy","volume":"28","author":"Wang","year":"2018","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.bcp.2025.117460_b0930","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.apt.2021.03.028","article-title":"Lipid composition optimization in spray congealing technique and testing with curcumin-loaded microparticles","volume":"32","author":"Sorita","year":"2021","journal-title":"Adv. Powder Technol."},{"key":"10.1016\/j.bcp.2025.117460_b0935","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1016\/j.bbamem.2012.06.019","article-title":"Comparative studies of polyethylene glycol-modified liposomes prepared using different PEG-modification methods","volume":"1818","author":"Nakamura","year":"2012","journal-title":"Biochimica et Biophysica Acta (BBA)-Biomembranes"},{"key":"10.1016\/j.bcp.2025.117460_b0940","doi-asserted-by":"crossref","unstructured":"V. Nagati, S. Tenugu, A.K. Pasupulati, Stability of therapeutic nano-drugs during storage and transportation as well as after ingestion in the human body, in: Advances in nanotechnology-based drug delivery systems, Elsevier, 2022, pp. 83-102.","DOI":"10.1016\/B978-0-323-88450-1.00020-X"},{"key":"10.1016\/j.bcp.2025.117460_b0945","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13205-020-2144-3","article-title":"Recent strategies towards the surface modification of liposomes: an innovative approach for different clinical applications","volume":"10","author":"Khan","year":"2020","journal-title":"3 Biotech"},{"key":"10.1016\/j.bcp.2025.117460_b0950","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1039\/D1TB01485D","article-title":"Effect of liposome surface modification with water-soluble phospholipid polymer chain-conjugated lipids on interaction with human plasma proteins","volume":"10","author":"Adler","year":"2022","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.bcp.2025.117460_b0955","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1039\/D2LC00463A","article-title":"Liposome manufacturing under continuous flow conditions: towards a fully integrated set-up with in-line control of critical quality attributes","volume":"23","author":"Sheybanifard","year":"2023","journal-title":"Lab Chip"},{"key":"10.1016\/j.bcp.2025.117460_b0960","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1002\/bit.27461","article-title":"Technology outlook for real\u2010time quality attribute and process parameter monitoring in biopharmaceutical development\u2014A review","volume":"117","author":"Wasalathanthri","year":"2020","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.bcp.2025.117460_b0965","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1111\/1541-4337.12701","article-title":"Microstructures of encapsulates and their relations with encapsulation efficiency and controlled release of bioactive constituents: A review","volume":"20","author":"Yun","year":"2021","journal-title":"Compr. Rev. Food Sci. Food Saf."},{"key":"10.1016\/j.bcp.2025.117460_b0970","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118722","article-title":"Freeze-drying cycle optimization for the rapid preservation of protein-loaded liposomal formulations","volume":"573","author":"Hussain","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bcp.2025.117460_b0975","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.addr.2019.03.003","article-title":"Lyophilized liposome-based parenteral drug development: Reviewing complex product design strategies and current regulatory environments","volume":"151","author":"Wang","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bcp.2025.117460_b0980","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3390\/pharmaceutics14030543","article-title":"Methods of liposomes preparation: Formation and control factors of versatile nanocarriers for biomedical and nanomedicine application","volume":"14","author":"Lombardo","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bcp.2025.117460_b0985","article-title":"Repurposing antitumor drugs for the treatment of non-oncological diseases: Mechanistic insights, clinical evidence, and future perspectives","volume":"117118","author":"Zhu","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117460_b0990","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00210-022-02245-z","article-title":"Nanotechnology in drug and gene delivery","volume":"395","author":"Hamimed","year":"2022","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117460_b0995","article-title":"Recent progress in synthesis of nano based liposomal drug delivery systems: A glance to their medicinal applications","volume":"100124","author":"Khafoor","year":"2023","journal-title":"Results Surf. Interfaces"},{"key":"10.1016\/j.bcp.2025.117460_b1000","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3390\/pharmaceutics14040821","article-title":"Targeted liposomes: A nonviral gene delivery system for cancer therapy","volume":"14","author":"Luiz","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bcp.2025.117460_b1005","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41417-019-0141-7","article-title":"Liposomal delivery of CRISPR\/Cas9","volume":"27","author":"Zhen","year":"2020","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.bcp.2025.117460_b1010","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.tibtech.2013.09.007","article-title":"Ligand-targeted liposome design: challenges and fundamental considerations","volume":"32","author":"Noble","year":"2014","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.bcp.2025.117460_b1015","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1038\/s41467-018-05384-1","article-title":"Enhanced immunocompatibility of ligand-targeted liposomes by attenuating natural IgM absorption","volume":"9","author":"Guan","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2025.117460_b1020","doi-asserted-by":"crossref","first-page":"5822","DOI":"10.1039\/C9NR00207C","article-title":"Liposome-based probes for molecular imaging: from basic research to the bedside","volume":"11","author":"Xia","year":"2019","journal-title":"Nanoscale"},{"key":"10.1016\/j.bcp.2025.117460_b1025","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.3390\/molecules28093798","article-title":"Radiolabeled Liposomes for Nuclear Imaging Probes","volume":"28","author":"Low","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2025.117460_b1030","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1039\/C6CS00765A","article-title":"Advanced optoacoustic methods for multiscale imaging of in vivo dynamics","volume":"46","author":"De\u00e1n-Ben","year":"2017","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bcp.2025.117460_b1035","doi-asserted-by":"crossref","DOI":"10.1016\/j.pacs.2023.100533","article-title":"Niche preclinical and clinical applications of photoacoustic imaging with endogenous contrast","author":"John","year":"2023","journal-title":"Photoacoustics"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225007257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225007257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T05:00:01Z","timestamp":1775797201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225007257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":207,"alternative-id":["S0006295225007257"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117460","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review on tumor-targeting liposomes: Fabrication, mechanism and applications","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117460","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117460"}}